We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Regulations in China Focus Tightly on Adverse Event Reporting
New Regulations in China Focus Tightly on Adverse Event Reporting
As part of its vast overhaul of its drugs and devices regulatory system, China has been placing a heavy emphasis on postmarket surveillance over the last two years.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor